SARS vaccines and methods to produce highly potent antibodies

Details for Australian Patent Application No. 2005251738 (hide)

Owner New York Blood Center, Inc.

Inventors Liu, Shuwen; He, Yuxian; Jiang, Shibo

Agent Patent Attorney Services

Pub. Number AU-A-2005251738

PCT Pub. Number WO2005/120565

Priority 60/576,118 02.06.04 US; 11/141,925 31.05.05 US

Filing date 1 June 2005

Wipo publication date 22 December 2005

International Classifications

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

C07K 14/165 (2006.01) Peptides having more than 20 amino acids

Event Publications

1 February 2007 PCT application entered the National Phase

  PCT publication WO2005/120565 Priority application(s): WO2005/120565

9 April 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005251740-Preparation for localized delivery of therapeutic agent

2005251735-Quinolineand isoquinoline-based compounds exhibiting ATP-utilizing enzyme inhibitory activity, and compositions, and uses thereof